EGF Receptor Is Required for KRAS-Induced Pancreatic Tumorigenesis
Authors:
Top Cited Papers
- 1 September 2012
- journal article
- Published by Elsevier in Cancer Cell
- Vol. 22 (3) , 304-317
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Krebshilfe (109992)
- Bundesministerium für Forschung, Technologie und Raumfahrt (01GS08115)
- Austrian Science Fund (W1212)
- Vanderbilt University Medical Center
- European Commission (LSHC-CT-2006-037731)
- Deutsche Forschungsgemeinschaft (SFB824/C4)
- National Institutes of Health (P01HL018645, R01CA159222, R01HL067267, R03CA129579)
- Mayo Clinic (P50CA095103)
This publication has 52 references indexed in Scilit:
- Pancreatitis-Induced Inflammation Contributes to Pancreatic Cancer by Inhibiting Oncogene-Induced SenescenceCancer Cell, 2011
- Oncogenic KRas Suppresses Inflammation-Associated Senescence of Pancreatic Ductal CellsCancer Cell, 2010
- Expression of oncogenic K‐ras and loss of Smad4 cooperate to induce the expression of EGFR and to promote invasion of immortalized human pancreas ductal cellsInternational Journal of Cancer, 2010
- Context-Dependent Transformation of Adult Pancreatic Cells by Oncogenic K-RasCancer Cell, 2009
- Ras Activity Levels Control the Development of Pancreatic DiseasesGastroenterology, 2009
- Acute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic KrasBiochemical and Biophysical Research Communications, 2009
- In Vivo Lineage Tracing Defines the Role of Acinar-to-Ductal Transdifferentiation in Inflammatory Ductal MetaplasiaGastroenterology, 2007
- The EGF receptor is required for efficient liver regenerationProceedings of the National Academy of Sciences, 2007
- Chronic Pancreatitis Is Essential for Induction of Pancreatic Ductal Adenocarcinoma by K-Ras Oncogenes in Adult MiceCancer Cell, 2007
- Both p16 Ink4a and the p19 Arf -p53 pathway constrain progression of pancreatic adenocarcinoma in the mouseProceedings of the National Academy of Sciences, 2006